Nothing to do with prostate cancer (yet), but …

According to an article by Andrew Pollack in today’s issue of the New York Times, a company called Osisris Therapeutics has achieved the first-ever approval to market a therapy based on stem cells — in Canada, for children with a condition known as graft versus host disease or GvHD, which is a well-recognized complication of bone marrow transplantation. … READ MORE …

Prostate cancer news reports: Monday, October 25, 2010

Today’s news reports address:

  • Urinary estrogen metabolites and prostate cancer risk
  • Prostate hyperthermia in combination with radiation and hormone therapy
  • Stem cells and development of androgen resistance
  • Reviews of the appropriate management of high-risk, localized prostate cancer and the use of androgen deprivation therapy (ADT) … READ MORE …

Is some prostate cancer caused by “luminal” stem cells?

On Tuesday this week we reported on a study suggesting that some prostate cancers might be caused by the XMRV virus. Now comes a study suggesting that specific types of stems cells may be implicated in the development of some prostate cancers. … READ MORE …